Vemurafenib induces senescence features in melanoma cells (Q39209913)

10 September 2017

Vemurafenib induces senescence features in melanoma cells (English)

1 reference

10 September 2017

Sebastian Haferkamp

1

1 reference

10 September 2017

Andreas Borst

2

1 reference

10 September 2017

Christian Adam

3

1 reference

10 September 2017

Therese M Becker

4

1 reference

10 September 2017

Stephanie Motschenbacher

5

1 reference

10 September 2017

Simone Windhövel

6

1 reference

10 September 2017

Anita L Hufnagel

7

1 reference

10 September 2017

Roland Houben

8

1 reference

10 September 2017

Svenja Meierjohann

9

1 reference

10 September 2017

language of work or name

English

0 references

publication date

14 February 2013

1 reference

Journal of Investigative Dermatology

10 September 2017

1 reference

10 September 2017

133

1 reference

10 September 2017

6

1 reference

10 September 2017

1601-1609

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2013.6

10 September 2017

0 references

cites work

Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Senescence: a new weapon for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Mechanisms of resistance to RAF inhibitors in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Tumour cell survival signalling by the ERK1/2 pathway

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Knockdown of B-Raf impairs spindle formation and the mitotic checkpoint in human somatic cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2013.6

1 reference

7 January 2021

Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Many roads lead to oncogene-induced senescence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Systematic review of medical treatment in melanoma: current status and future prospects.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Comment on “Absence of Senescence-Associated β-Galactosidase Activity in Human Melanocytic Nevi In Vivo”

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

p16INK4a-induced senescence is disabled by melanoma-associated mutations

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Inhibition of VEGF induces cellular senescence in colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Regulation of c-myc expression by Ras/Raf signalling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Glimpses of evolution: heterochromatic histone H3K9 methyltransferases left its marks behind

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Comment on “Absence of Senescence-Associated β-Galactosidase Activity in Human Melanocytic Nevi In Vivo”

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2013.6

1 reference

7 January 2021

Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Never-ageing cellular senescence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Targeted molecular therapy in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Specifically targeting ERK1 or ERK2 kills melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

The INK4a/ARF locus and melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Absence of distinguishing senescence traits in human melanocytic nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Regulation of E2Fs and senescence by PML nuclear bodies.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.6

7 January 2021

Identifiers

DOI

10.1038/JID.2013.6

1 reference

10 September 2017

1 reference